Healthcare

Combating The Opioid Crisis In The Pharmacy

It’s happening again. Another pharmacy operator is facing federal prosecution for allegedly mismanaging prescription opioids and violating the Controlled Substances Act. And the civil penalties being sought by the Department of Justice could total in the billions of dollars.

• Read more about Combating The Opioid Crisis In The Pharmacy

Who’s Guiding You Through The Digital Transformation Of Healthcare?

Learn how Inmar is enabling this digital transformation -- helping healthcare organizations better protect patients, meet their regulatory responsibilities and mitigate risk throughout the drug supply chain.

• Read more about Who’s Guiding You Through The Digital Transformation Of Healthcare?

Without Insights and Information, Needed Improvement is Impossible

Inmar Intelligence has the pharmacy solutions for retail pharmacies to increase revenue.

• Read more about Without Insights and Information, Needed Improvement is Impossible

Making The Case for Robust Drug Diversion Monitoring in Your Hospital System

Understand the organizational commitment required to effectively prevent and consistently address drug diversion in the clinical setting.

• Read more about Making The Case for Robust Drug Diversion Monitoring in Your Hospital System

What Pharma Manufacturers Need to Know about Consumer Drug Take-Back

As jurisdictions across the U.S. continue implementing and enforcing disparate legislation mandating drug take-back programs, the burden of funding and execution for these programs has fallen upon pharmaceutical manufacturers. 

• Read more about What Pharma Manufacturers Need to Know about Consumer Drug Take-Back

Rx Audit Management: A Tool for the Times

Payers and PBMs have demonstrated much needed flexibility during the Covid-19 pandemic and their willingness to accommodate pharmacies has enabled providers to successfully contend with any number of business and operational challenges. However, as progress against the pandemic continues to accelerate and focus returns to more “normal” business activity, the likelihood of increased pharmacy audits is growing.

• Read more about Rx Audit Management: A Tool for the Times

How Your Facility Can Harness AI to Get Ahead of Drug Diversion

Clinical drug diversion is a critical issue in pharmacies and health systems nationwide. Healthcare workers who steal or misuse controlled substances (CS) cause direct harm to patients and put their employers at risk for financial penalties and sanctions.   Presented by Dwight de Vera, GM Healthcare Intelligence at Inmar, and Nick Culbertson, Co-Founder and CEO at Protenus, this webinar explores the following:

• Read more about How Your Facility Can Harness AI to Get Ahead of Drug Diversion

Accelerating Healthcare: Drug Diversion Surveillance

While the Covid-19 pandemic continues to dominate the news, coverage of America’s “other” health crisis -- the opioid epidemic -- has fallen off the front page, even as the damage and death it’s bringing to our country grows. In the 12 months ending in May 2020, the Centers for Disease Control and Prevention recorded more than 81,000 overdose deaths -- the most ever recorded in a 12-month period by the Centers.

• Read more about Accelerating Healthcare: Drug Diversion Surveillance

Five Questions Every Pharmacy Manager Should Ask About Physical Inventory

Pharmacy physical inventory is a critical but sometimes disruptive process within the healthcare system. But getting an accurate on-hand product count doesn’t have to interfere with everyday pharmacy operations. By engaging proven experts and asking the right questions, pharmacy managers can identify the best options available for driving improved inventory efficiency in support of greater profitability. So, here are five questions that pharmacy managers should ask to make sure they’re getting the professional inventory services they need -- and should expect. 

• Read more about Five Questions Every Pharmacy Manager Should Ask About Physical Inventory